C. Sultan

13.6k total citations · 5 hit papers
29 papers, 10.6k citations indexed

About

C. Sultan is a scholar working on Hematology, Emergency Medicine and Genetics. According to data from OpenAlex, C. Sultan has authored 29 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 9 papers in Emergency Medicine and 7 papers in Genetics. Recurrent topics in C. Sultan's work include Acute Myeloid Leukemia Research (17 papers), Hematological disorders and diagnostics (9 papers) and Chronic Lymphocytic Leukemia Research (4 papers). C. Sultan is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Hematological disorders and diagnostics (9 papers) and Chronic Lymphocytic Leukemia Research (4 papers). C. Sultan collaborates with scholars based in France, United States and Switzerland. C. Sultan's co-authors include Georges Flandrin, John M. Bennett, Daniel Catovsky, H. R. Gralnick, D. A. G. Galton, MT Daniel, D. A. G. Galton, D Catovsky, Michèle Imbert and Harvey R. Gralnick and has published in prestigious journals such as The Lancet, Blood and Cancer.

In The Last Decade

C. Sultan

29 papers receiving 10.0k citations

Hit Papers

Proposals for the Classification of the Acute Leukaemias ... 1976 2026 1992 2009 1976 1982 1982 1989 1991 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Sultan France 19 8.8k 3.1k 2.8k 2.8k 1.5k 29 10.6k
H. R. Gralnick United States 21 7.9k 0.9× 2.7k 0.9× 2.8k 1.0× 2.8k 1.0× 1.5k 1.0× 34 10.6k
Peter L. Greenberg United States 45 9.1k 1.0× 3.8k 1.2× 3.2k 1.1× 1.4k 0.5× 1.0k 0.7× 203 11.0k
Azra Raza United States 50 8.8k 1.0× 3.6k 1.1× 5.5k 1.9× 1.4k 0.5× 1.3k 0.9× 278 12.3k
Aristoteles Giagounidis Germany 49 8.5k 1.0× 3.7k 1.2× 3.4k 1.2× 1.5k 0.5× 692 0.5× 259 10.3k
Eva Hellström‐Lindberg Sweden 40 8.2k 0.9× 3.8k 1.2× 4.0k 1.4× 1.4k 0.5× 960 0.6× 187 10.6k
David R. Head United States 35 6.5k 0.7× 1.5k 0.5× 3.2k 1.1× 3.1k 1.1× 504 0.3× 90 8.8k
Anna Porwit Sweden 34 4.4k 0.5× 2.6k 0.8× 2.2k 0.8× 1.3k 0.5× 877 0.6× 173 7.3k
Ghulam J. Mufti United Kingdom 55 7.7k 0.9× 2.9k 0.9× 4.0k 1.4× 1.3k 0.5× 2.2k 1.5× 268 11.2k
David Grimwade United Kingdom 50 12.7k 1.5× 3.0k 0.9× 8.4k 3.0× 4.5k 1.6× 874 0.6× 152 15.6k
Claude Preudhomme France 62 9.4k 1.1× 4.4k 1.4× 5.7k 2.0× 2.4k 0.9× 1.3k 0.8× 356 13.3k

Countries citing papers authored by C. Sultan

Since Specialization
Citations

This map shows the geographic impact of C. Sultan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sultan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sultan more than expected).

Fields of papers citing papers by C. Sultan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sultan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sultan. The network helps show where C. Sultan may publish in the future.

Co-authorship network of co-authors of C. Sultan

This figure shows the co-authorship network connecting the top 25 collaborators of C. Sultan. A scholar is included among the top collaborators of C. Sultan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Sultan. C. Sultan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suri, R. & C. Sultan. (2022). Myelodysplastic syndromes. Nature Reviews Disease Primers. 8(1). 251–4. 1 indexed citations
3.
Imbert, Michèle, et al.. (1992). Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Leukemia Research. 16(1). 51–54. 19 indexed citations
4.
Bennett, John M., Daniel Catovsky, Georges Flandrin, et al.. (1991). Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO). British Journal of Haematology. 78(3). 325–329. 514 indexed citations breakdown →
5.
Bennett, John M., D Catovsky, MT Daniel, et al.. (1989). Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.. Journal of Clinical Pathology. 42(6). 567–584. 565 indexed citations breakdown →
6.
Sultan, C., Michèle Gouault-Heilmann, & Michèle Imbert. (1985). Manual of hematology. J. Wiley eBooks. 6 indexed citations
7.
Sultan, C., et al.. (1985). Evaluation of the interest in ordering the leucocyte differential count. Social Science & Medicine. 21(10). 1177–1179. 2 indexed citations
8.
Scoazec, Jean‐Yves, Michèle Imbert, Hélène Jouault, et al.. (1985). Myelodysplastic syndrome or acute myeloid leukemia? A study of 28 cases presenting with borderline features. Cancer. 55(10). 2390–2394. 18 indexed citations
9.
Farcet, JP, et al.. (1984). Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood. 63(4). 779–783. 25 indexed citations
10.
Juneja, Surender, Michèle Imbert, H Jouault, et al.. (1983). Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.. Journal of Clinical Pathology. 36(10). 1129–1135. 64 indexed citations
11.
Bennett, John M., Daniel Catovsky, MT Daniel, et al.. (1982). Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology. 51(2). 189–199. 2952 indexed citations breakdown →
12.
Bennett, John M., et al.. (1982). Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology. 51(2). 189–199. 993 indexed citations breakdown →
13.
Sultan, C., et al.. (1981). Distribution of 250 Cases of Acute Myeloid Leukaemia (AML) according to the FAB Classification and Response to Therapy. British Journal of Haematology. 47(4). 545–551. 50 indexed citations
14.
Sultan, C., F Sigaux, Michèle Imbert, & F Reyes. (1981). Acute Myelodysplasia with Myelofibrosis: a Report of Eight Cases. British Journal of Haematology. 49(1). 11–16. 103 indexed citations
15.
Intrator, L, Claire André, C Chenal, & C. Sultan. (1979). A monoclonal macroglobulin with antinuclear activity.. Journal of Clinical Pathology. 32(5). 450–454. 13 indexed citations
16.
Bennett, John M., Daniel Catovsky, Georges Flandrin, et al.. (1976). Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group. British Journal of Haematology. 33(4). 451–458. 4454 indexed citations breakdown →
17.
Zittoun, J, R Zittoun, J Marquet, & C. Sultan. (1975). The Three Transcobalamins in Myeloproliferative Disorders and Acute Leukaemia. British Journal of Haematology. 31(3). 287–298. 45 indexed citations
18.
Sultan, C., et al.. (1975). [Study of certain idiopathic and secondary acquired myelopoietic disorders, using bone marrow culture in vitro].. PubMed. 125(6-7). 599–602. 8 indexed citations
19.
Sultan, C., et al.. (1973). Relationship between Blast‐Cell Morphology and Occurrence of a Syndrome of Disseminated Intravascular Coagulation. British Journal of Haematology. 24(2). 255–259. 56 indexed citations
20.
Boiron, M, C Jacquillat, M Weil, et al.. (1969). DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA. The Lancet. 293(7590). 330–333. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026